Efficacy of Ceftibuten for Acute Otitis Media Caused by Hemophilus Influenzae: an Animal Study
Efficacy of Ceftibuten for Acute Otitis Media Caused by Hemophilus Influenzae: an Animal Study
复制标题
头孢布烯治疗流感嗜血杆菌引起的急性中耳炎的疗效:动物研究
DOI:
10.1177/000348949310200310
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
Israel Greene
中科院分区:
文献类型:
--
作者:
Richard M. Rosenfeld;William J. Doyle;J. Seroky;J. Swarts;Israel Greene
Ceftibuten is a new oral cephalosporin with an unusual stability to β-lactamases that can hydrolyze other extended-spectrum cephalosporins. Using the chinchilla animal model, we compared the efficacy of ceftibuten (n = 33) with that of saline (n = 34), ampicillin (n = 32), and cefixime (n = 31) for the treatment of acute otitis media caused by β-lactamase—producing nontypeable Hemophilus influenzae. Ceftibuten was superior to ampicillin regarding the time necessary to sterilize the middle ear (p < .001) and eliminate effusion (p < .001). The mean days of therapy required for bacteriologic cure were 2.57 for ceftibuten, 2.95 for cefixime, 7.95 for ampicillin, and 8.16 for saline. At the conclusion of therapy, chinchillas treated with ceftibuten had a significantly lower prevalence of positive cultures and middle ear effusion than did animals treated with ampicillin. No significant differences were observed between ceftibuten and cefixime. The results of this randomized, investigator-blinded experiment warrant further consideration of ceftibuten as a second-line agent for acute otitis media caused by ampicillin-resistant H influenzae.
DOI:
10.1001/archotol.1987.01860040032011
发表时间:
1987
期刊:
Archives of otolaryngology--head & neck surgery
影响因子:
--
作者:
Hotaling,AJ;Doyle,WJ;Cantekin,EI
通讯作者:
Cantekin,EI